Holen Sie sich die Stockscreener-App
5.1101
1.81%
-0.0899
Schlusskurs vom Vortag:
$5.20
Offen:
$5.225
24-Stunden-Volumen:
1.91M
Relative Volume:
0.39
Marktkapitalisierung:
$1.22B
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-16.31
EPS:
-0.3134
Netto-Cashflow:
$-63.80M
1W Leistung:
+20.42%
1M Leistung:
+17.37%
6M Leistung:
-8.50%
1J Leistung:
-8.01%
1-Tages-Spanne:
$5.01
$5.31
1-Wochen-Bereich:
$4.075
$5.4899
52-Wochen-Spanne:
$3.21
$7.18
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.115 | 1.24B | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.97 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.46 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.12 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
669.59 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.21 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2025-03-04 | Eingeleitet | BTIG Research | Buy |
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Ardelyx price target raised to $9 from $8 at Piper Sandler - TipRanks
Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX) - MSN
Insiders Of Ardelyx Are Up 20% On Their US$6.78m Purchase - 富途牛牛
Ardelyx, Inc. (NASDAQ:ARDX) Q2 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ardelyx Inc Faces Uncertainty Amid Shifting Trade Policies - AInvest
Ardelyx Inc. Faces Financial Uncertainty Amid Shifting Trade Policies - TipRanks
Ardelyx Q2 Revenue Jumps 33% - AOL.com
Ardelyx Inc. Q2 2025 Earnings Call Highlights - TipRanks
BTIG Remains a Buy on Ardelyx (ARDX) With a $14 PT - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming By Stocktwits - Investing.com India
Ardelyx Surpasses Expectations with Remarkable Q2 Performance - timothysykes.com
Ardelyx Stock Soars: Time to Buy? - StocksToTrade
Ardelyx shares rise 13.21% premarket after reporting strong Q2 revenue growth and raising 2025 sales expectations. - AInvest
Ardelyx Inc (ARDX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada
Ardelyx Names New CMO and CTOO, Appoints CFO - AInvest
Ardelyx Reports Strong Q2 2025 Financial Performance - TipRanks
Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth - MSN
Ardelyx's Q2 2025 Earnings Call: Key Contradictions in XPHOZAH and IBSRELA Growth Strategies - AInvest
Ardelyx (ARDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq
Earnings call transcript: Ardelyx Q2 2025 beats earnings expectations By Investing.com - Investing.com UK
Earnings call transcript: Ardelyx Q2 2025 beats earnings expectations - Investing.com
Ardelyx: Q2 Earnings Snapshot - San Antonio Express-News
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates - sg.finance.yahoo.com
Ardelyx CFO Transition Announced Amid Strong Q2 Results - TipRanks
Ardelyx Inc earnings beat by $0.05, revenue topped estimates - Investing.com
Ardelyx, Inc. Announces Executive Leadership Changes: Edward Conner, M.D. Appointed CMO and John Bishop, Ph.D. as CTOO; Justin Renz to Transition Out as CFOO - Quiver Quantitative
Ardelyx Announces Changes to the Executive Leadership Team - GlobeNewswire
Ardelyx Reshapes Executive Team: New CMO and CTOO Join as CFO Departs in Strategic Growth Move - Stock Titan
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update - The Globe and Mail
Spotlight On 3 Promising Penny Stocks With Over $20M Market Cap - simplywall.st
What makes Ardelyx Inc. stock price move sharplyAccelerated profit realization - Jammu Links News
Is Ardelyx Inc. stock overvalued or undervaluedInvest confidently with professional advice - Jammu Links News
When is Ardelyx Inc. stock expected to show significant growthBoost your wealth with consistent growth stocks - Jammu Links News
Should I hold or sell Ardelyx Inc. stock in 2025Gain insights from top financial experts - Jammu Links News
Does Ardelyx Inc. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News
What is the dividend policy of Ardelyx Inc. stockIdentify undervalued stocks ready to soar - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How volatile is Ardelyx Inc. stock compared to the marketBuild a portfolio that grows with the market - Jammu Links News
Is Ardelyx Inc. a good long term investmentInvest with confidence backed by data - Jammu Links News
How does Ardelyx Inc. generate profit in a changing economyMassive portfolio appreciation - Jammu Links News
How does Ardelyx Inc. compare to its industry peersGain insights from top financial experts - Jammu Links News
How strong is Ardelyx Inc. company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What are analysts’ price targets for Ardelyx Inc. in the next 12 monthsFree Wealth Management Insights - Jammu Links News
Why is Ardelyx Inc. stock attracting strong analyst attentionInvest confidently with actionable market data - Jammu Links News
How Increased Analyst Caution Could Shape Ardelyx (ARDX) Earnings Expectations and Investor Sentiment - simplywall.st
What to Expect From Ardelyx's Earnings - 富途牛牛
Ardelyx (ARDX) Rated as ‘Overweight’ at Cantor Fitzgerald amid Ibsrela Sales Growth Expectation - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):